Camp4 Therapeutics (CAMP) EBT (2023 - 2026)
Camp4 Therapeutics recorded quarterly EBT of -$12.2 million in Q1 2026, down 0.79% quarter-over-quarter from -$12.1 million in Q4 2025, and up 2.81% year-over-year from -$11.8 million in Q1 2025.
Camp4 Therapeutics' EBT history runs 4 years deep, the most recent figure standing at -$12.2 million for Q1 2026.
- In Q1 2026, EBT rose 2.81% year-over-year to -$12.2 million; the TTM figure through Mar 2026 stood at -$50.0 million (up 3.24% YoY), while the FY2025 annual figure was -$50.6 million, up 2.35% from the prior year.
- EBT came in at -$12.2 million for Q1 2026 at Camp4 Therapeutics, down from -$12.1 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$11.7 million in Q3 2023 to a low of -$13.5 million in Q3 2024.
- A 4-year average of -$12.6 million and a median of -$12.5 million in 2025 frame the typical range for EBT.
- Across the five-year window, EBT fell 15.29% in 2024 and grew 9.13% in 2025, its largest moves.
- Camp4 Therapeutics' EBT stood at -$13.0 million in 2023, then decreased by 2.22% to -$13.3 million in 2024, then climbed by 9.13% to -$12.1 million in 2025, then dropped by 0.79% to -$12.2 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$12.2 million, -$12.1 million, and -$13.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.31 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.18 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 831.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 221.65 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | -12.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.16 Mn |
| Dec 31, 2025 | -12.07 Mn |
| Sep 30, 2025 | -13.23 Mn |
| Jun 30, 2025 | -12.58 Mn |
| Mar 31, 2025 | -12.51 Mn |
| Dec 31, 2024 | -13.28 Mn |
| Sep 30, 2024 | -13.48 Mn |
| Jun 30, 2024 | -12.43 Mn |
| Mar 31, 2024 | -12.48 Mn |
| Dec 31, 2023 | -12.99 Mn |
| Sep 30, 2023 | -11.70 Mn |